Last updated on May 2020

A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)


Brief description of study

This is a prospective, multicenter, open-label, randomized, controlled, parallel group, group-sequential, event-driven Phase 3 study to evaluate efficacy, safety and pharmacokinetics (PK) of macitentan in children.

Clinical Study Identifier: NCT02932410

Find a site near you

Start Over

Phoenix Childrens Hospital

Phoenix, AZ United States
  Connect »

UCLA Children's Heart Center

Los Angeles, CA United States
  Connect »

Texas Children's Hospital

Houston, TX United States
  Connect »

UCSF Medical Center

San Francisco, CA United States
  Connect »

Detroit Medical Center

Detroit, MI United States
  Connect »

East Carolina University

Greenville, NC United States
  Connect »

Children's Heart Center

Las Vegas, NV United States
  Connect »

Primary Children's Medical Center

Salt Lake City, UT United States
  Connect »

Riley Hospital For Children

Indianapolis, IN United States
  Connect »

Mayo Clinic - PPDS

Rochester, MN United States
  Connect »

H pital Des Enfants

Toulouse Cedex 9, France
  Connect »

CICUM San Miguel

Guadalajara, Mexico
  Connect »

Makati Medical Center

Makati City, Philippines
  Connect »

Philippine Heart Center

Quezon City, Philippines
  Connect »

Clinical Hospital 1

Tyumen, Russian Federation
  Connect »

University of The Free State

Bloemfontein, South Africa
  Connect »

Children's Hospital 1

Ho Chi Minh City, Vietnam
  Connect »

Tam Duc Hospital

Ho Chi Minh, Vietnam
  Connect »

University of Virginia Health System

Charlottesville, VA United States
  Connect »

H pital Des Enfants

Toulouse Cedex 9, France
  Connect »

Clinical Hospital 1

Tyumen, Russian Federation
  Connect »